216 related articles for article (PubMed ID: 26895640)
21. Women's views of the climacteric at the time of low menopausal hormone use, Estonia 1998.
Hovi SL; Veerus P; Karro H; Topo P; Hemminki E
Maturitas; 2005 Aug; 51(4):413-25. PubMed ID: 16039416
[TBL] [Abstract][Full Text] [Related]
22. Menopausal hormone therapy: physician awareness of patient attitudes.
Ghali WA; Freund KM; Boss RD; Ryan CA; Moskowitz MA
Am J Med; 1997 Jul; 103(1):3-10. PubMed ID: 9236479
[TBL] [Abstract][Full Text] [Related]
23. Midlife women making hormone therapy decisions.
MacLaren A; Woods NF
Womens Health Issues; 2001; 11(3):216-30. PubMed ID: 11336862
[TBL] [Abstract][Full Text] [Related]
24. Understanding the menopausal experiences of professional women.
Simon JA; Reape KZ
Menopause; 2009; 16(1):73-6. PubMed ID: 18779760
[TBL] [Abstract][Full Text] [Related]
25. Changing use of hormone therapy among minority women since the Women's Health Initiative.
Helenius IM; Korenstein D; Halm EA
Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
[TBL] [Abstract][Full Text] [Related]
26. Women's sexuality: from aging to social representations.
Ringa V; Diter K; Laborde C; Bajos N
J Sex Med; 2013 Oct; 10(10):2399-408. PubMed ID: 23890152
[TBL] [Abstract][Full Text] [Related]
27. Women's decision making about the use of natural health products at menopause: a needs assessment and patient decision aid.
Légaré F; Stacey D; Dodin S; O'Connor A; Richer M; Griffiths F; LeBlanc A; Rousseau JL; Tapp S
J Altern Complement Med; 2007 Sep; 13(7):741-49. PubMed ID: 17931067
[TBL] [Abstract][Full Text] [Related]
28. The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment.
Kingsberg SA; Krychman M; Graham S; Bernick B; Mirkin S
J Sex Med; 2017 Mar; 14(3):413-424. PubMed ID: 28202320
[TBL] [Abstract][Full Text] [Related]
29. Lifestyle risk management--a qualitative analysis of women's descriptions of taking hormone therapy following surgically induced menopause.
Crowe M; Burrell B; Whitehead L
J Adv Nurs; 2012 Aug; 68(8):1814-23. PubMed ID: 22082259
[TBL] [Abstract][Full Text] [Related]
30. The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs.
Nappi RE; Palacios S; Particco M; Panay N
Maturitas; 2016 Sep; 91():81-90. PubMed ID: 27451325
[TBL] [Abstract][Full Text] [Related]
31. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
Skouby SO; Barlow D; Samsioe G; Gompel A; Pines A; Al-Azzawi F; Graziottin A; Hudita D; Rozenberg S;
Maturitas; 2004 May; 48(1):19-25. PubMed ID: 15223104
[TBL] [Abstract][Full Text] [Related]
32. Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it.
Ekström H
Maturitas; 2005 Oct; 52(2):154-64. PubMed ID: 16186078
[TBL] [Abstract][Full Text] [Related]
33. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
Col NF; Guthrie JR; Politi M; Dennerstein L
Menopause; 2009; 16(3):453-7. PubMed ID: 19188852
[TBL] [Abstract][Full Text] [Related]
34. Coping with menopausal symptoms: An internet survey of Belgian postmenopausal women.
Depypere H; Pintiaux A; Desreux J; Hendrickx M; Neven P; Marchowicz E; Albert V; Leclercq V; Van den Branden S; Rozenberg S
Maturitas; 2016 Aug; 90():24-30. PubMed ID: 27282790
[TBL] [Abstract][Full Text] [Related]
35. NIH State-of-the-Science Conference Statement on management of menopause-related symptoms.
NIH Consens State Sci Statements; 2005 Mar 21-23; 22(1):1-38. PubMed ID: 17308548
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer survivors' attitudes and understanding of menopause and hormone therapy.
Cotangco K; Class QA; Johnson TP; Kothari R
Menopause; 2020 Jun; 27(6):701-705. PubMed ID: 32108734
[TBL] [Abstract][Full Text] [Related]
37. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
[TBL] [Abstract][Full Text] [Related]
38. A symptomatic approach to understanding women's health experiences: a cross-cultural comparison of women aged 20 to 70 years.
Dennerstein L; Lehert P; Koochaki PE; Graziottin A; Leiblum S; Alexander JL
Menopause; 2007; 14(4):688-96. PubMed ID: 17290159
[TBL] [Abstract][Full Text] [Related]
39. Women's decisions about whether or not to take hormone replacement therapy: influence of social and medical factors.
Griffiths F
Br J Gen Pract; 1995 Sep; 45(398):477-80. PubMed ID: 7546871
[TBL] [Abstract][Full Text] [Related]
40. Perceptions of Postmenopausal Symptoms and Treatment Options among Middle-Aged Korean Women.
Kim MK; Seo SK; Chae HD; Hwang KJ; Kim T; Yoon BK; Lee BS
Yonsei Med J; 2017 May; 58(3):533-539. PubMed ID: 28332358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
